JOHN NIEDERHUBER

M.D., CEO, INOVA TRANSLATIONAL MEDICINE INSTITUTE

Dr. Niederhuber brings a lifetime of medical knowledge, large organization management experience and vision to his position as CEO, including his most recent tenure as director of the National Cancer Institute (NCI). A nationally renowned surgeon and researcher, he has dedicated his four-decade career to the treatment and study of cancer. He has served as professor, cancer center director, National Cancer Advisory Board chair, external advisor to NCI, grant reviewer, and laboratory investigator supported by NCI and National Institutes of Health. He previously served as NCI’s chief operating officer and deputy director for translational and clinical sciences and chair of the National Cancer Advisory Board (NCAB). He remains involved in research at his laboratory on the National Institutes of Health (NIH) campus. Dr. Niederhuber is a member of the Institute of Medicine of the National Academy of Science and has received numerous honors and awards.